Home › Clear-cell metastatic renal cell carcinoma › California › Los Angeles
Clear-cell metastatic renal cell carcinoma clinical trials in Los Angeles, CA
3 studies for Clear-cell metastatic renal cell carcinoma are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
RecruitingPhase 3
- Research Site, Los Angeles
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
- Investigational Drug Services, Bowyer Pharmacy, Los Angeles
- Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles
- UCLA Hematology/Oncology, Los Angeles
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RecruitingPhase 3
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles County-USC Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- and 2 more
Clear-cell metastatic renal cell carcinoma trials in other cities
- Baldwin Park, CA6 studies
- St. Louis, MO5 studies
- Nashville, TN5 studies
- Dallas, TX5 studies
- Waukegan, IL4 studies
- New York City, NY4 studies
- Rochester, MN4 studies
- Cleveland, OH4 studies
- Ann Arbor, MI3 studies
- Irvine, CA3 studies
- Philadelphia, PA3 studies
- Boston, MA3 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer92 studies
- Breast Cancer73 studies
- Cancer (all types)73 studies
- Prostate Cancer64 studies
- Colorectal Cancer61 studies
- Metastatic Cancer57 studies
- Ovarian Cancer53 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma43 studies
- Pancreatic Cancer36 studies
- Endometrial Cancer35 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.